Buyout
Fund focus: Re-ups underpin FountainVest's Fund IV close
Despite headwinds that have afflicted all China-focused managers, FountainVest Partners closed its fourth fund just above target on USD 2.9bn. One-third of the corpus has already been deployed
Fund focus: LPs endorse Potentia’s software thesis
Potentia Capital took just four months to close its second fund on USD 438m, emphasizing the growing appeal of B2B technology opportunities in Australia and New Zealand
Australia’s Potentia closes Fund II on $438m
Australian technology-focused private equity firm Potentia Capital has achieved a first and final close of AUD 635m (USD 438m) on its second fund, hitting the hard cap and beating a target of AUD 500m.
Korea's Hahn & Co targets $3.25b for Fund IV
Hahn & Company has set a target of USD 3.25bn for its fourth Korea-focused fund, which will include a co-investment sidecar of unspecified size.
DCP hits $2.5b first close on second China fund
DCP Capital has already completed five investments from its second China fund, having completed a first close of USD 2.5bn in January.
Trustar seeks $3.5b for fifth China buyout fund
Trustar Capital, formerly known as CITIC Capital Partners, is looking to raise USD 3.5bn for its fifth China buyout fund and USD 250m for a debut growth vehicle.
Advent raises $25bn for global PE fund, targets China
Advent International has closed its largest ever global private equity fund at the hard cap of USD 25bn with plans to expand its investment activity in Greater China in the next few years.
Japan's J-Star closes fifth fund on $574m
Japanese lower middle-market private equity firm J-Star has closed its fifth flagship fund at the hard cap of JPY 75bn (USD 574m). The target was JPY 65m.
Australia's Mercury targets $595m for Fund IV
Australian mid-market private equity firm Mercury Capital is targeting AUD 800m (USD 595m) for its fourth fund.
India's True North to target local LPs for Fund VII
India-based middle-market private equity firm True North will make a concerted effort to market to domestic LPs for the first time on launching its seventh fund in the second quarter.
CVC seeks $6b for latest Asia fund
CVC Capital Partners will launch its sixth Asia fund in April with a target of at least USD 6bn, stepping up from USD 4.5bn in the previous vintage.
EQT and Baring Asia: Size matters
The significance of EQT’s acquisition of Baring Private Equity Asia is in the strategic machinations of global GPs as much as in the implications for on-the-ground dealmaking
Goldman leads $900m stapled secondary for Baring Asia
Baring Private Equity Asia (BPEA) has completed a stapled secondary of nearly USD 900m, which saw an investor consortium commit capital to its eighth fund and take out positions in two earlier vehicles.
Australia's IFM hits first close on long-hold fund
Australia’s IFM Investors has reached a first close of AUD 450m (USD 337m) on a long-term private capital (LTPC) fund designed to hold assets for 10 years or more. The overall target is around AUD 1bn.
Australia's BGH closes Fund II on $2.6b
BGH Capital has closed its second fund on approximately AUD 3.6bn (USD 2.6bn) after fewer than six months in the market. It represents the largest-ever private equity vehicle raised for deployment in Australia and New Zealand.
AVCJ Awards 2021: Fundraise of the Year – Large Cap: KKR
Working around travel restrictions and reaching into the high-net-worth segment were key themes as KKR raised USD 15bn for its fourth pan-Asia fund, the largest vehicle of its kind to date
Q&A: Sylvan Group’s Gerald Leong
Gerald Leong, a 25-year veteran of Asian private equity, believes returns-focused impact investment is the future of the industry. His new firm, Singapore-based Sylvan Group, will attempt to prove it
Crescendo closes third Korea fund on $910m
Korean middle-market private equity firm Crescendo Equity Partners has confirmed a final close of USD 910m on its third flagship fund, beating a target of USD 700m.
GP profile: Creador
Creador claims to be Southeast Asia’s only middle-market GP with on-the-ground capacities across the region. But in-house post-deal support and nimble deal sourcing are its key differentiators
Singapore's Sylvan buys four local healthcare companies
Sylvan Group, a Singaporean private equity firm set up by Hyundai scion Kyungsun Chung, has acquired majority stakes in four local healthcare companies for USD 140.5m. These represent its first investments.
AVCJ Awards 2021: Special Achievement: Weijian Shan
Weijian Shan, CEO of PAG, discusses rising valuations, the implications of China’s regulatory crackdown, heightened sensitivity around social responsibility, and escalating fund sizes
Australia’s BGH sets $2.5b hard cap for Fund II
BGH Capital has set the hard cap for its second Australia and New Zealand-focused fund at approximately AUD 3.5bn (USD 2.5bn), having reached a first close of AUD 3bn.
2022 preview: China fundraising
Investors held fire on commitments to China managers amid uncertainty over regulatory reforms. Industry participants hope the government will provide clarity, but the fear LPs won’t hurry back
Mizuho spinout targets $263m for Japan buyout fund
MCP Capital (MCPC), a Japanese lower mid-market buyout firm that spun out from Mizuho Bank earlier this year, is looking to raise up to JPY30 billion ($263.2 million) for its sixth fund.
